Clinical trial
Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
NCT02394431 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
- Lead sponsor
- Brugmann University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- June 30, 2016
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease